Fosaprepitant Not Yet Recruiting Phase 4 Trials for Chemotherapy-Induced Nausea and Vomiting / Breast Cancer Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT05841849Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer